Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy
- PMID: 30610793
Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy
Abstract
Purpose: To investigate the relationship between the expression of miR150 and FOXO4 in nasopharyngeal carcinoma (NPC) and the local recurrence and metastasis after intensive radiotherapy.
Methods: 94 patients with NPC were selected in Hunan Provincial People's Hospital from May 2011 to May 2013. All patients received intensive radiotherapy. Thirty healthy controls were also included. The expression levels of miR150 and FOXO4 mRNA in blood lymphocytes were detected by RT-PCR. All patients with NPC were followed up for 36 months. Blood was drawn from patients to analyze the expression of miR150 and FOXO4. MiR150 inhibitor was used to treat NPC cells, and FOXO4 overexpression cell lines were established. Transwell invasion assay was performed to investigate the effects of miR150 expression inhibition and FOXO4 overexpression on cell invasion. Protein levels were detected by western blot.
Results: Compared with healthy controls, the levels of miR150 mRNA in NPC patients were significantly increased, while FOXO4 mRNA levels were significantly decreased (p<0.05). The levels of miR150 and FOXO4 were significantly correlated with distant metastasis and tumor recurrence (p<0.05). High expression level of miR150 or low expression level of FOXO4 significantly shortened the overall survival (OS) of patients (p<0.05). Cox's proportional hazards model showed that miR150 and FOXO4 were potential independent risk factors for NPC (p<0.05). The level of miR150 in patients with tumor recurrence was significantly higher than that in patients without tumor recurrence, while the level of FOXO4 in patients with tumor recurrence was lower than that patients without tumor recurrence (p<0.05). MiR150 expression inhibition or FOXO4 overexpression significantly reduced the invasion abilities of CNE1 and CNE2 cells and protein levels of matrix metalloproteinase2 (MMP2) and MMP9 (p<0.05).
Conclusion: MiR150 and FOXO4 are closely related to the metastasis and recurrence of NPC, and are independent prognostic factors for NPC. MiR150 and FOXO4 are of clinical significance in predicting NPC prognosis.
Similar articles
-
Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.Curr Cancer Drug Targets. 2020;20(8):624-637. doi: 10.2174/1568009620666200424145122. Curr Cancer Drug Targets. 2020. PMID: 32329689
-
Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.Oncotarget. 2016 Mar 22;7(12):13634-50. doi: 10.18632/oncotarget.7215. Oncotarget. 2016. PMID: 26872369 Free PMC article.
-
Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.Tumour Biol. 2016 Jun;37(6):8169-79. doi: 10.1007/s13277-015-4686-2. Epub 2015 Dec 29. Tumour Biol. 2016. PMID: 26715277
-
Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).Int J Oncol. 2021 Apr;58(4):9. doi: 10.3892/ijo.2021.5188. Epub 2021 Mar 2. Int J Oncol. 2021. PMID: 33649830 Free PMC article. Review.
-
Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma.Genes (Basel). 2022 Jun 27;13(7):1160. doi: 10.3390/genes13071160. Genes (Basel). 2022. PMID: 35885944 Free PMC article. Review.
Cited by
-
Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.Front Pharmacol. 2022 Jun 30;13:909821. doi: 10.3389/fphar.2022.909821. eCollection 2022. Front Pharmacol. 2022. PMID: 35847022 Free PMC article. Review.
-
A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma.Front Oncol. 2021 Oct 7;11:710525. doi: 10.3389/fonc.2021.710525. eCollection 2021. Front Oncol. 2021. PMID: 34692488 Free PMC article.
-
A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.Cancers (Basel). 2021 Aug 29;13(17):4369. doi: 10.3390/cancers13174369. Cancers (Basel). 2021. PMID: 34503179 Free PMC article. Review.
-
Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis.Cell Death Discov. 2021 Aug 11;7(1):210. doi: 10.1038/s41420-021-00596-9. Cell Death Discov. 2021. PMID: 34381023 Free PMC article. Review.
-
The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review.Front Cell Dev Biol. 2021 May 31;9:683254. doi: 10.3389/fcell.2021.683254. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34136491 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
